OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,115,531 | -38.1% | 673,736 | +1.7% | 0.00% | -100.0% |
| Q2 2023 | $3,418,552 | -1.3% | 662,510 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $3,462,901 | +88.0% | 657,097 | +0.2% | 0.00% | – |
| Q4 2022 | $1,842,393 | -32.0% | 655,656 | +0.4% | 0.00% | -100.0% |
| Q3 2022 | $2,710,000 | +1.0% | 652,877 | -2.2% | 0.00% | 0.0% |
| Q2 2022 | $2,684,000 | -25.6% | 667,581 | -8.4% | 0.00% | 0.0% |
| Q1 2022 | $3,609,000 | -32.3% | 729,160 | -4.7% | 0.00% | 0.0% |
| Q4 2021 | $5,331,000 | -28.5% | 764,977 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $7,456,000 | -33.4% | 745,500 | -5.6% | 0.00% | -50.0% |
| Q2 2021 | $11,198,000 | -13.5% | 789,621 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $12,946,000 | -20.0% | 788,944 | +0.9% | 0.00% | -33.3% |
| Q4 2020 | $16,178,000 | +211.7% | 781,570 | +14.6% | 0.00% | +200.0% |
| Q3 2020 | $5,190,000 | -3.4% | 681,989 | +5.7% | 0.00% | 0.0% |
| Q2 2020 | $5,373,000 | +110.3% | 644,955 | +25.0% | 0.00% | 0.0% |
| Q1 2020 | $2,555,000 | +35.5% | 516,101 | +8.1% | 0.00% | – |
| Q4 2019 | $1,885,000 | +27.2% | 477,383 | -2.1% | 0.00% | – |
| Q3 2019 | $1,482,000 | -19.8% | 487,423 | +16.1% | 0.00% | – |
| Q2 2019 | $1,848,000 | +14.4% | 419,982 | +3.3% | 0.00% | – |
| Q1 2019 | $1,615,000 | +0.6% | 406,733 | +0.8% | 0.00% | – |
| Q4 2018 | $1,606,000 | -40.0% | 403,442 | +3.7% | 0.00% | -100.0% |
| Q3 2018 | $2,676,000 | +9.4% | 388,949 | +7.3% | 0.00% | 0.0% |
| Q2 2018 | $2,447,000 | +15.9% | 362,627 | +11.7% | 0.00% | 0.0% |
| Q1 2018 | $2,112,000 | +81.4% | 324,526 | +24.1% | 0.00% | – |
| Q4 2017 | $1,164,000 | -28.2% | 261,533 | -0.3% | 0.00% | – |
| Q3 2017 | $1,622,000 | -33.3% | 262,401 | +0.1% | 0.00% | -100.0% |
| Q2 2017 | $2,430,000 | +13.1% | 262,139 | +13.2% | 0.00% | 0.0% |
| Q1 2017 | $2,149,000 | +28.7% | 231,600 | +16.1% | 0.00% | 0.0% |
| Q4 2016 | $1,670,000 | +15.6% | 199,440 | -5.2% | 0.00% | – |
| Q3 2016 | $1,445,000 | +50.7% | 210,345 | +8.5% | 0.00% | – |
| Q2 2016 | $959,000 | -39.1% | 193,804 | +18.9% | 0.00% | -100.0% |
| Q1 2016 | $1,575,000 | +3.3% | 163,049 | +0.2% | 0.00% | 0.0% |
| Q4 2015 | $1,525,000 | -30.7% | 162,768 | +4.0% | 0.00% | 0.0% |
| Q3 2015 | $2,200,000 | +54.9% | 156,476 | +131.6% | 0.00% | – |
| Q2 2015 | $1,420,000 | -42.2% | 67,552 | +15.5% | 0.00% | -100.0% |
| Q1 2015 | $2,455,000 | +78.8% | 58,470 | +0.1% | 0.00% | – |
| Q4 2014 | $1,373,000 | +717.3% | 58,384 | +420.2% | 0.00% | – |
| Q3 2014 | $168,000 | – | 11,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |